Tau is also a major component of neurofibrillary tangles (NFTs) in the brains of patients with tauopathies, including Alzheimer’s disease (AD), frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)4, 5, 6. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.